Torrent Pharma Increases Investment in Torrent Urja to ₹11.88 Cr

Torrent Pharmaceuticals Ltd. has enhanced its investment in Torrent Urja 27 Private Limited, a special purpose vehicle for a captive hybrid power project. The investment has increased from ₹7.92 Cr to ₹11.88 Cr, corresponding to an increase in project capacity. This move aims to boost the share of renewable power sources in the company's operations and comply with regulatory requirements for captive users. Torrent Urja is an associate company and a step-down subsidiary of Torrent Pharma's holding company, and the transaction is conducted on an arm's length basis. The acquisition of a 26% stake in Torrent Urja is expected to be completed within 18 to 21 months.